Compare LWAY & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LWAY | CGC |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Pharmaceuticals and Biotechnology |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.4M | 467.3M |
| IPO Year | 1995 | 2023 |
| Metric | LWAY | CGC |
|---|---|---|
| Price | $25.01 | $0.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | 158.4K | ★ 3.8M |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.33 | ★ 84.17 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $103,350,000.00 | $12,759,000.00 |
| Revenue This Year | $16.64 | $8.27 |
| Revenue Next Year | $17.28 | $15.68 |
| P/E Ratio | $82.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $0.84 |
| 52 Week High | $34.20 | $2.38 |
| Indicator | LWAY | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 46.53 |
| Support Level | $22.86 | $0.96 |
| Resistance Level | $27.76 | $1.23 |
| Average True Range (ATR) | 0.90 | 0.04 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 40.76 | 14.18 |
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.